Skip to content
Research Article Open access CC BY 4.0

A Review on Zika Virus: Epidemiology, Pathogenesis and Clinical Outcomes

Rhoda Nwalozie, Roseanne Adah Ikpeama, Brenda Anyakwe Nnokam, Rose Mary Kaiso Esiere

International Journal of Pathogen Research · pp. 35–41 · Published 19 Jun 2023

10.9734/ijpr/2023/v12i3229

Abstract

A single-stranded RNA virus of the Flaviviridae family, the Zika virus is mainly spread by Aedes mosquitoes. Zika virus infection was originally thought to be a mild and self-limiting illness when it was first discovered in Uganda in 1947. Infection in pregnant women, causes serious congenital abnormalities, including microcephaly, a condition marked by an abnormally small head and brain size, was only discovered in 2015 as a result of a significant outbreak in Brazil. Since then, the Zika virus has caused on-going outbreaks throughout the globe, raising serious concerns about public health. Despite significant research efforts, there is currently no cure or vaccine for Zika virus infection, and mosquito control and safe sexual behaviour continue to be the major ways to cut down on transmission. It is crucial to maintain surveillance and study in order to comprehend the epidemiology, pathogenesis, and clinical outcomes of Zika virus infection and to create efficient prevention and treatment plans.

Zika virus aedes mosquito public health infection

References (26)

  1. 1 Zika Virus (I). Isolations and serological specificity [DOI]
  2. 2 Zika Virus Infection in Pregnant Women in Rio de Janeiro [DOI]
  3. 3 Zika Virus and Birth Defects — Reviewing the Evidence for Causality [DOI]
  4. 4 Zika Virus [DOI]
  5. 5 Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study [DOI]
  6. 6 Zika Virus in the Americas — Yet Another Arbovirus Threat [DOI]
  7. 7 Zika virus: History, emergence, biology, and prospects for control [DOI]
  8. 8 Differential Susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika Virus [DOI]
  9. 9 A Literature Review of Zika Virus [DOI]
  10. 10 Guillain–Barré Syndrome Associated with Zika Virus Infection in Colombia [DOI]
  11. 11 Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study [DOI]
  12. 12 Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys [DOI]
  13. 13 Zika Virus Spreads to New Areas — Region of the Americas, May 2015–January 2016 [DOI]
  14. 14 Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas [DOI]
  15. 15 The changing epidemiology of dengue in China, 1990-2014: a descriptive analysis of 25 years of nationwide surveillance data [DOI]
  16. 16 Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine [DOI]
  17. 17 Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials [DOI]
  18. 18 Evaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked Immunosorbent Assays for Zika Virus Serologic Testing [DOI]
  19. 19 Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure — United States, July 2016 [DOI]
  20. 20 Investigational Testing for Zika Virus among U.S. Blood Donors [DOI]
  21. 21 Evaluation of Malaria Parasitaemia among COVID-19 Patients in Rivers State, Nigeria [DOI]
  22. 22 The Effect of Latitudinal Variation on Shrimp Reproductive Strategies [DOI]
  23. 23 The Prevalence of Malaria in COVID-19 Patients among Blood Group Classification [DOI]
  24. 24 Update From the Advisory Committee on Immunization Practices [DOI]
  25. 25 Zika, chikungunya and dengue: the causes and threats of new and re-emerging arboviral diseases [DOI]
  26. 26 Centers for Disease Control and Prevention [DOI]

Cited by 2

Insights into the structure, functional perspective, and pathogenesis of ZIKV: an updated review

Eijaz Ahmed Bhat, Tufail Ali, Nasreena Sajjad · Biomedicine & Pharmacotherapy · 2023

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

2

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.